Clinical trial

An Extension Study Administering YM155 to Subjects Previously Enrolled in Another Protocol Administering YM155

NCT00818480

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2006-02-01

PhasePHASE2

Study timeline

Study start (unknown)2006-02-01Date precision: month

Registry last updated2015-09-04

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Prostate Cancerunresolved

Melanomaunresolved

Non-Hodgkin's Lymphomaunresolved

Interventions

YM155DRUG

Sponsors & collaborators

Astellas Pharma Inclead sponsor

Mapped research locations

San AntonioTexas, United States2 Salt Lake CityUtah, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00818480 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.